In this issue:
Ribavirin and SVR in HCV genotype 2
HCC risk in HCV cirrhosis and diabetes
Short-duration therapy for hepatitis C
Predicting NASH by clinical scoring
Predictors of HCC inBudd-Chiari syndrome
Virology, histology inHBV and normal ALT
Terlipressin for type 1
Please login below to download this issue (PDF)